China Insomnia Therapy Market Report & Forecast 2021-2027
Table of Contents1 Introduction to Research & Analysis Reports
1.1 Insomnia Therapy Market Definition
1.2 Market Segments
1.2.1 Segment by Type
1.2.2 Segment by Application
1.3 China Insomnia Therapy Market Overview
1.4 Methodology & Sources of Information
1.4.1 Research Methodology
1.4.2 Research Process
1.4.3 Base Year
2 China Insomnia Therapy Overall Market Size
2.1 China Insomnia Therapy Market Size: 2021 VS 2027
2.2 China Insomnia Therapy Revenue, Prospects & Forecasts: 2016-2027
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Insomnia Therapy Players in China Market
3.2 Top China Insomnia Therapy Companies Ranked by Revenue
3.3 China Insomnia Therapy Revenue by Companies
3.4 Top 3 and Top 5 Insomnia Therapy Companies in China Market, by Revenue in 2020
3.5 Companies Insomnia Therapy Product Type
3.6 Tier 1, Tier 2 and Tier 3 Insomnia Therapy Players in China Market
3.6.1 List of Tier 1 Insomnia Therapy Companies in China
3.6.2 List of Tier 2 and Tier 3 Insomnia Therapy Companies in China
4 Sights by Type
4.1 Overview
4.1.1 By Type - China Insomnia Therapy Market Size Markets, 2021 & 2027
4.1.2 Non-pharmacological Therapy
4.1.3 Pharmacological Therapy
4.2 By Type - China Insomnia Therapy Revenue & Forecasts
4.2.1 By Type - China Insomnia Therapy Revenue, 2016-2021
4.2.2 By Type - China Insomnia Therapy Revenue, 2022-2027
4.2.3 By Type - China Insomnia Therapy Revenue Market Share, 2016-2027
5 Sights by Application
5.1 Overview
5.1.1 By Application - China Insomnia Therapy Market Size, 2021 & 2027
5.1.2 Hospital
5.1.3 Ambulatory Surgical Center
5.1.4 Home Care
5.2 By Application - China Insomnia Therapy Revenue & Forecasts
5.2.1 By Application - China Insomnia Therapy Revenue, 2016-2021
5.2.2 By Application - China Insomnia Therapy Revenue, 2022-2027
5.2.3 By Application - China Insomnia Therapy Revenue Market Share, 2016-2027
6 Insomnia Therapy Companies Profiles
6.1 Merck & Co.
6.1.1 Merck & Co. Company Details
6.1.2 Merck & Co. Business Overview
6.1.3 Merck & Co. Insomnia Therapy Introduction
6.1.4 Merck & Co. Insomnia Therapy Revenue in China Market (2016-2021)
6.1.5 Merck & Co. Recent Developments
6.2 Sanofi
6.2.1 Sanofi Company Details
6.2.2 Sanofi Business Overview
6.2.3 Sanofi Insomnia Therapy Introduction
6.2.4 Sanofi Insomnia Therapy Revenue in China Market (2016-2021)
6.2.5 Sanofi Recent Developments
6.3 Pfizer
6.3.1 Pfizer Company Details
6.3.2 Pfizer Business Overview
6.3.3 Pfizer Insomnia Therapy Introduction
6.3.4 Pfizer Insomnia Therapy Revenue in China Market (2016-2021)
6.3.5 Pfizer Recent Developments
6.4 Takeda Pharmaceutical Company Ltd.
6.4.1 Takeda Pharmaceutical Company Ltd. Company Details
6.4.2 Takeda Pharmaceutical Company Ltd. Business Overview
6.4.3 Takeda Pharmaceutical Company Ltd. Insomnia Therapy Introduction
6.4.4 Takeda Pharmaceutical Company Ltd. Insomnia Therapy Revenue in China Market (2016-2021)
6.4.5 Takeda Pharmaceutical Company Ltd. Recent Developments
6.5 Purdue Pharmaceuticals L.P.
6.5.1 Purdue Pharmaceuticals L.P. Company Details
6.5.2 Purdue Pharmaceuticals L.P. Business Overview
6.5.3 Purdue Pharmaceuticals L.P. Insomnia Therapy Introduction
6.5.4 Purdue Pharmaceuticals L.P. Insomnia Therapy Revenue in China Market (2016-2021)
6.5.5 Purdue Pharmaceuticals L.P. Recent Developments
6.6 Eisai, Co. Ltd.
6.6.1 Eisai, Co. Ltd. Company Details
6.6.2 Eisai, Co. Ltd. Business Overview
6.6.3 Eisai, Co. Ltd. Insomnia Therapy Introduction
6.6.4 Eisai, Co. Ltd. Insomnia Therapy Revenue in China Market (2016-2021)
6.6.5 Eisai, Co. Ltd. Recent Developments
6.7 Meda Consumer Healthcare
6.7.1 Meda Consumer Healthcare Company Details
6.7.2 Meda Consumer Healthcare Business Overview
6.7.3 Meda Consumer Healthcare Insomnia Therapy Introduction
6.7.4 Meda Consumer Healthcare Insomnia Therapy Revenue in China Market (2016-2021)
6.7.5 Meda Consumer Healthcare Recent Developments
6.8 Pernix Therapeutics
6.8.1 Pernix Therapeutics Company Details
6.8.2 Pernix Therapeutics Business Overview
6.8.3 Pernix Therapeutics Insomnia Therapy Introduction
6.8.4 Pernix Therapeutics Insomnia Therapy Revenue in China Market (2016-2021)
6.8.5 Pernix Therapeutics Recent Developments
6.9 Vanda Pharmaceuticals
6.9.1 Vanda Pharmaceuticals Company Details
6.9.2 Vanda Pharmaceuticals Business Overview
6.9.3 Vanda Pharmaceuticals Insomnia Therapy Introduction
6.9.4 Vanda Pharmaceuticals Insomnia Therapy Revenue in China Market (2016-2021)
6.9.5 Vanda Pharmaceuticals Recent Developments
6.10 ECR Pharmaceuticals
6.10.1 ECR Pharmaceuticals Company Details
6.10.2 ECR Pharmaceuticals Business Overview
6.10.3 ECR Pharmaceuticals Insomnia Therapy Introduction
6.10.4 ECR Pharmaceuticals Insomnia Therapy Revenue in China Market (2016-2021)
6.10.5 ECR Pharmaceuticals Recent Developments
6.11 Fidia Farmaceutici
6.11.1 Fidia Farmaceutici Company Details
6.11.2 Fidia Farmaceutici Business Overview
6.11.3 Fidia Farmaceutici Insomnia Therapy Introduction
6.11.4 Fidia Farmaceutici Insomnia Therapy Revenue in China Market (2016-2021)
6.11.5 Fidia Farmaceutici Recent Developments
6.12 Dainippon Sumitomo
6.12.1 Dainippon Sumitomo Company Details
6.12.2 Dainippon Sumitomo Business Overview
6.12.3 Dainippon Sumitomo Insomnia Therapy Introduction
6.12.4 Dainippon Sumitomo Insomnia Therapy Revenue in China Market (2016-2021)
6.12.5 Dainippon Sumitomo Recent Developments
6.13 Biocodex
6.13.1 Biocodex Company Details
6.13.2 Biocodex Business Overview
6.13.3 Biocodex Insomnia Therapy Introduction
6.13.4 Biocodex Insomnia Therapy Revenue in China Market (2016-2021)
6.13.5 Biocodex Recent Developments
6.14 Eli Lilly and Company
6.14.1 Eli Lilly and Company Company Details
6.14.2 Eli Lilly and Company Business Overview
6.14.3 Eli Lilly and Company Insomnia Therapy Introduction
6.14.4 Eli Lilly and Company Insomnia Therapy Revenue in China Market (2016-2021)
6.14.5 Eli Lilly and Company Recent Developments
6.15 Ebb Therapeutics
6.15.1 Ebb Therapeutics Company Details
6.15.2 Ebb Therapeutics Business Overview
6.15.3 Ebb Therapeutics Insomnia Therapy Introduction
6.15.4 Ebb Therapeutics Insomnia Therapy Revenue in China Market (2016-2021)
6.15.5 Ebb Therapeutics Recent Developments
7 Conclusion
8 Appendix
8.1 Note
8.2 Examples of Clients
8.3 Author Details
8.4 Disclaimer
List of TablesTable 1. Insomnia Therapy Market Opportunities & Trends in China Market
Table 2. Insomnia Therapy Market Drivers in China Market
Table 3. Insomnia Therapy Market Restraints in China Market
Table 4. Key Players of Insomnia Therapy in China Market
Table 5. Top Insomnia Therapy Players in China Market, Ranking by Revenue (2019)
Table 6. China Insomnia Therapy Revenue by Companies, (US$, Mn), 2016-2021
Table 7. China Insomnia Therapy Revenue Share by Companies, 2016-2021
Table 8. Companies Insomnia Therapy Product Type
Table 9. List of Tier 1 Insomnia Therapy Companies, Revenue (US$, Mn) in 2020 and Market Share
Table 10. List of Tier 2 and Tier 3 Insomnia Therapy Companies, Revenue (US$, Mn) in 2020 and Market Share
Table 11. By Type - China Insomnia Therapy Revenue, (US$, Mn), 2021 & 2027
Table 12. By Type - China Insomnia Therapy Revenue (US$, Mn), 2016-2021
Table 13. By Type - China Insomnia Therapy Revenue (US$, Mn), 2022-2027
Table 14. By Application - China Insomnia Therapy Revenue, (US$, Mn), 2021 VS 2027
Table 15. By Application - China Insomnia Therapy Revenue (US$, Mn), 2016-2021
Table 16. By Application - China Insomnia Therapy Revenue (US$, Mn), 2022-2027
Table 17. Merck & Co. Company Details
Table 18. Merck & Co. Business Overview
Table 19. Merck & Co. Insomnia Therapy Product
Table 20. Merck & Co. Insomnia Therapy Revenue in China Market (2016-2021) & (US$ Million)
Table 21. Merck & Co. Recent Developments
Table 22. Sanofi Company Details
Table 23. Sanofi Business Overview
Table 24. Sanofi Insomnia Therapy Product
Table 25. Sanofi Insomnia Therapy Revenue in China Market (2016-2021) & (US$ Million)
Table 26. Sanofi Recent Developments
Table 27. Pfizer Company Details
Table 28. Pfizer Business Overview
Table 29. Pfizer Insomnia Therapy Product
Table 30. Pfizer Insomnia Therapy Revenue in China Market (2016-2021) & (US$ Million)
Table 31. Pfizer Recent Developments
Table 32. Takeda Pharmaceutical Company Ltd. Company Details
Table 33. Takeda Pharmaceutical Company Ltd. Business Overview
Table 34. Takeda Pharmaceutical Company Ltd. Insomnia Therapy Product
Table 35. Takeda Pharmaceutical Company Ltd. Insomnia Therapy Revenue in China Market (2016-2021) & (US$ Million)
Table 36. Takeda Pharmaceutical Company Ltd. Recent Developments
Table 37. Purdue Pharmaceuticals L.P. Company Details
Table 38. Purdue Pharmaceuticals L.P. Business Overview
Table 39. Purdue Pharmaceuticals L.P. Insomnia Therapy Product
Table 40. Purdue Pharmaceuticals L.P. Insomnia Therapy Revenue in China Market (2016-2021) & (US$ Million)
Table 41. Purdue Pharmaceuticals L.P. Recent Developments
Table 42. Eisai, Co. Ltd. Company Details
Table 43. Eisai, Co. Ltd. Business Overview
Table 44. Eisai, Co. Ltd. Insomnia Therapy Product
Table 45. Eisai, Co. Ltd. Insomnia Therapy Revenue in China Market (2016-2021) & (US$ Million)
Table 46. Eisai, Co. Ltd. Recent Developments
Table 47. Meda Consumer Healthcare Company Details
Table 48. Meda Consumer Healthcare Business Overview
Table 49. Meda Consumer Healthcare Insomnia Therapy Product
Table 50. Meda Consumer Healthcare Insomnia Therapy Revenue in China Market (2016-2021) & (US$ Million)
Table 51. Meda Consumer Healthcare Recent Developments
Table 52. Pernix Therapeutics Company Details
Table 53. Pernix Therapeutics Business Overview
Table 54. Pernix Therapeutics Insomnia Therapy Product
Table 55. Pernix Therapeutics Insomnia Therapy Revenue in China Market (2016-2021) & (US$ Million)
Table 56. Pernix Therapeutics Recent Developments
Table 57. Vanda Pharmaceuticals Company Details
Table 58. Vanda Pharmaceuticals Business Overview
Table 59. Vanda Pharmaceuticals Insomnia Therapy Product
Table 60. Vanda Pharmaceuticals Insomnia Therapy Revenue in China Market (2016-2021) & (US$ Million)
Table 61. Vanda Pharmaceuticals Recent Developments
Table 62. ECR Pharmaceuticals Company Details
Table 63. ECR Pharmaceuticals Business Overview
Table 64. ECR Pharmaceuticals Insomnia Therapy Product
Table 65. ECR Pharmaceuticals Insomnia Therapy Revenue in China Market (2016-2021) & (US$ Million)
Table 66. ECR Pharmaceuticals Recent Developments
Table 67. Fidia Farmaceutici Company Details
Table 68. Fidia Farmaceutici Business Overview
Table 69. Fidia Farmaceutici Insomnia Therapy Product
Table 70. Fidia Farmaceutici Insomnia Therapy Revenue in China Market (2016-2021) & (US$ Million)
Table 71. Fidia Farmaceutici Recent Developments
Table 72. Dainippon Sumitomo Company Details
Table 73. Dainippon Sumitomo Business Overview
Table 74. Dainippon Sumitomo Insomnia Therapy Product
Table 75. Dainippon Sumitomo Insomnia Therapy Revenue in China Market (2016-2021) & (US$ Million)
Table 76. Dainippon Sumitomo Recent Developments
Table 77. Biocodex Company Details
Table 78. Biocodex Business Overview
Table 79. Biocodex Insomnia Therapy Product
Table 80. Biocodex Insomnia Therapy Revenue in China Market (2016-2021) & (US$ Million)
Table 81. Biocodex Recent Developments
Table 82. Eli Lilly and Company Company Details
Table 83. Eli Lilly and Company Business Overview
Table 84. Eli Lilly and Company Insomnia Therapy Product
Table 85. Eli Lilly and Company Insomnia Therapy Revenue in China Market (2016-2021) & (US$ Million)
Table 86. Eli Lilly and Company Recent Developments
Table 87. Ebb Therapeutics Business Overview
Table 88. Ebb Therapeutics Company Details
Table 89. Ebb Therapeutics Insomnia Therapy Product
Table 90. Ebb Therapeutics Insomnia Therapy Revenue in China Market (2016-2021) & (US$ Million)
Table 91. Ebb Therapeutics Recent Developments
List of FiguresFigure 1. Insomnia Therapy Segment by Type
Figure 2. Insomnia Therapy Segment by Application
Figure 3. China Insomnia Therapy Market Overview: 2020
Figure 4. China Insomnia Therapy Market Size: 2021 VS 2027 (US$, Mn)
Figure 5. China Insomnia Therapy Revenue, 2016-2027 (US$, Mn)
Figure 6. The Top 3 and 5 Players Market Share by Insomnia Therapy Revenue in 2020
Figure 7. By Type - China Insomnia Therapy Revenue Market Share, 2016-2027
Figure 8. By Application - China Insomnia Therapy Revenue Market Share, 2016-2027
Figure 9. Merck & Co. Insomnia Therapy Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 10. Sanofi Insomnia Therapy Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 11. Pfizer Insomnia Therapy Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 12. Takeda Pharmaceutical Company Ltd. Insomnia Therapy Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 13. Purdue Pharmaceuticals L.P. Insomnia Therapy Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 14. Eisai, Co. Ltd. Insomnia Therapy Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 15. Meda Consumer Healthcare Insomnia Therapy Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 16. Pernix Therapeutics Insomnia Therapy Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 17. Vanda Pharmaceuticals Insomnia Therapy Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 18. ECR Pharmaceuticals Insomnia Therapy Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 19. Fidia Farmaceutici Insomnia Therapy Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 20. Dainippon Sumitomo Insomnia Therapy Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 21. Biocodex Insomnia Therapy Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 22. Eli Lilly and Company Insomnia Therapy Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 23. Ebb Therapeutics Insomnia Therapy Revenue Year Over Year Growth (US$, Mn) & (2016-2021)